NASDAQ:ALHC - Nasdaq - US01625V1044 - Common Stock - Currency: USD
ALIGNMENT HEALTHCARE INC
NASDAQ:ALHC (1/27/2025, 11:20:43 AM)
15.15
+0.18 (+1.2%)
The current stock price of ALHC is 15.15 USD. In the past month the price increased by 39.78%. In the past year, price increased by 113.86%.
Explore this week's top-performing mid-cap stocks, including H&E Equipment Services' impressive 100.59% surge following an acquisition announcement by United Rentals. Discover why stocks like SEMrush and Blueprint Medicines also experienced significant gains, impacting investment portfolios positively.
Achieves 35% year-over-year growth to 209,900 members on Jan. 1, showing how Medicare Advantage can be done rightAnnounces year-end 2025 health plan...
ORANGE, Calif. , Dec. 30, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that it will present at the 43rd Annual...
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
UNH | UNITEDHEALTH GROUP INC | 19.45 | 499.71B | ||
ELV | ELEVANCE HEALTH INC | 12.47 | 95.37B | ||
HUM | HUMANA INC | 16.4 | 36.02B | ||
CNC | CENTENE CORP | 9.73 | 33.17B | ||
MOH | MOLINA HEALTHCARE INC | 14.26 | 17.93B | ||
HQY | HEALTHEQUITY INC | 34.18 | 9.09B | ||
CLOV | CLOVER HEALTH INVESTMENTS CO | N/A | 2.40B | ||
PGNY | PROGYNY INC | 39.21 | 1.94B | ||
NEUE | NEUEHEALTH INC | 5.59 | 61.18M |
Alignment Healthcare, Inc. operates as a holding company. The company is headquartered in Orange, California and currently employs 1,536 full-time employees. The company went IPO on 2021-03-26. The firm's operations consist of Medicare Advantage Plans in the states of California, North Carolina, Nevada, Arizona, Florida and Texas. Its consumer brand name, Alignment Health, offers more than 50 Medicare Advantage plans that serve 53 counties across six states. The company partners with nationally recognized and local providers to deliver coordinated care, powered by its customized care model, 24/7 concierge care team and purpose-built technology, Alignment's Virtual Application (AVA). AVA is designed specifically for senior care and provides end-to-end coordination of the healthcare ecosystem. AVA's suite of tools and services is built within a unified data architecture. Medicare Advantage plans are direct-to-consumer and provide a single point of care delivery for hospital insurance benefits, outpatient services and often prescription drug coverage.
ALIGNMENT HEALTHCARE INC
1100 W. Town And Country Road, Suite 1600
Orange CALIFORNIA 92868 US
CEO: John Kao
Employees: 1536
Company Website: https://www.alignmenthealth.com/
Investor Relations: http://ir.alignmenthealth.com/
Phone: 18443102247
The current stock price of ALHC is 15.15 USD.
The exchange symbol of ALIGNMENT HEALTHCARE INC is ALHC and it is listed on the Nasdaq exchange.
ALHC stock is listed on the Nasdaq exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for ALHC, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of ALHC.
ALHC does not pay a dividend.
ALHC does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.77).
The outstanding short interest for ALHC is 8.8% of its float.
ChartMill assigns a technical rating of 10 / 10 to ALHC. When comparing the yearly performance of all stocks, ALHC is one of the better performing stocks in the market, outperforming 95% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to ALHC. Both the profitability and financial health of ALHC have multiple concerns.
Over the last trailing twelve months ALHC reported a non-GAAP Earnings per Share(EPS) of -0.77. The EPS increased by 8.33% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -20.82% | ||
ROE | -125.84% | ||
Debt/Equity | 1.84 |
ChartMill assigns a Buy % Consensus number of 83% to ALHC. The Buy consensus is the average rating of analysts ratings from 19 analysts.
For the next year, analysts expect an EPS growth of 10.55% and a revenue growth 48.45% for ALHC